- Trials with a EudraCT protocol (0)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: A double-blind, multicenter, multi-dose, parallel group, placebo-controlled study on the efficacy and safety of a homeopathic combination remedy vs.placebo over 14 days of treatment in children with acute otitis media. |
| Active substance: Aconitum napellus Dil. D6 0,075 ml; Capsicum annuum Dil. D4 0,075 ml; Chamomilla recutita Ø 0,225 ml; Echinacea purpurea Ø 0,75 ml; Hydrargyrum bicyanatum Dil. D6 0,075 ml; Hydrastis canadensis Dil. D4 0,075 ml; Iodum Dil. D4 0,075 ml; Natrium tetraboracicum Dil. D4 0,075 ml; Sambucus nigra Ø 0,225 ml; Sanguinaria canadensis Ø 0,075 ml. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39772 |
| Study title: Medical report of a double-blind, placebo-controlled, crossover study, to evaluate the efficacy and safety of 3 daily doses of 4 mg BW825C in children (6-13 yrs) exhibiting the symptoms of perennial allergic rhinitis, conducted by Dr. E.G. Weinberg, Cape Town, South Africa. Report No. BRAH/85/0011/00 |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): Study H40-082-C86-Acrivastine.xls |
| View full study record |
| Document reference: 46227 |
| Study title: Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142.Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46222 |
| Study title: Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142.Ones−Ü, Tamay−Z. New oral antihistamines in pediatrics and safety of antihistamines in children. Current Medicinal Chemistry: Anti−Inflammatory and Anti−Allergy Agents. 2005, Vol/Iss /Pg. 4/5 (495−506), ISSN: 1568−0142. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46231 |
| Study title: Phase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold FormulaPhase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold Formula |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46248 |
| Study title: A STUDY OF THE EFFICACY AND SAFETY OF ADAPALENE 0.1% AND 0.3% GEL IN THE TREATMENT OF ACTINIC KERATOSES IN ORGAN TRANSPLANT PATIENTS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46293 |
| Study title: AN OPEN LABEL, CLINICAL SAFETY AND EFFICACY STUDY OF DIFFERIN (ADAPALENE) GEL IN THE TREATMENT OF FACIAL ACNE VULGARIS IN DARK PIGMENTED SKIN – SOUTH AFRICA |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46261 |
| Study title: CLINICAL SAFETY AND EFFICACY EVALUATION OF ADAPALENE 0.1 % GEL VERSUS TRETINOIN 0.025 % GEL (WITH PARTICULAR REFERENCE TO ONSET OF ACTION) IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46253 |
| Study title: CLINICAL SAFETY AND EFFICACY EVALUATION OF ADAPALENE 0.1% GEL VERSUS ISOTRETINOIN 0.05% GEL IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46292 |
| Study title: CLINICAL SAFETY AND EFFICACY EVALUATION OF ADAPALENE 0.1% GEL VERSUS TRETINOIN 0.025% GEL IN THE TREATMENT OF ACNE VULGARIS – PHASE IV – CHINA |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46262 |
| Study title: CLINICAL SAFETY AND EFFICACY EVALUATION OF ADAPALENE 0.1% GEL VERSUS VEHICLE IN THE TREATMENT OF ACNE VULGARIS – Mexico |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46259 |
| Study title: CLINICAL STUDY PROTOCOL - EFFICACY AND SAFETY OF ADAPALENE GEL IN TWO CONCENTRATIONS (0.1% AND 0.03%) AND ITS VEHICLE IN THE TREATMENT OF JAPANESE SUBJECTS WITH ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46289 |
| Study title: COMPARISON OF EFFICACY AND SAFETY OF TETRALYSAL 300MG PLUS DIFFERIN GEL 0.1% VERSUS TETRALYSAL 300MG PLUS DIFFERIN GEL VEHICLE IN SUBJECTS WITH ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46285 |
| Study title: HALF-FACE COMPARISON OF THE SAFETY AND EFFICACY OF DIFFERIN (ADAPALENE GEL) GEL, 0.1% VERSUS TAZORAC (TAZAROTENE GEL) GEL, 0.1% AND RETIN-A MICRO (TRETINOIN GEL) GEL, 0.1% IN SUBJECTS WITH ACNE VULGARIS - PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46272 |
| Study title: SAFETY AND EFFICACY COMPARISON OF DIFFERIN (ADAPALENE GEL) GEL, 0.1% AND RETIN-A GEL, 0.025% IN THE TREATMENT OF ACNE VULGARIS - PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46267 |
| Study title: SAFETY AND EFFICACY COMPARISON OF DIFFERIN (ADAPALENE GEL) GEL, 0.1 % VERSUS RETIN-A CREAM, 0.05 % IN SUBJECTS WITH ACNE VULGARIS – PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46258 |
| Study title: US - A LONG TERM SAFETY AND EFFICACY STUDY OF ADAPALENE GEL, 0,3% IN SUBJECTS WITH ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46277 |
| Study title: US - A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF ADAPALENE/BENZOYL PEROXIDE TOPICAL GEL COMPARED WITH ADAPALENE TOPICAL GEL, 0.1%; BENZOYL PEROXIDE TOPICAL GEL, 2.5% AND TOPICAL GEL VEHICLE IN SUBJECTS WITH ACNE VULGARIS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46284 |
| Study title: US - EFFICACY AND SAFETY OF ADAPALENE GEL, 0.3% COMPARED TO TAZAROTENE GEL, 0.1% IN THE TREATMENT OF ACNE VULGARIS - PHASE IIIB |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46283 |
| Study title: A phase IV double-blind single dose evaluation of the safety and efficacy of acetaminophen 1000 mg, aspirin 650 mg, and placebo in the treatment of pain following oral surgery. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 2-231.pdf |
| View full study record |
| Document reference: 47205 |
